knowledge landing page image

KWM advises UBS on $471 Million Oncology Impact Fund

News

King & Wood Mallesons advises UBS Wealth Management on $471 Million Oncology Impact Fund

King & Wood Mallesons has advised UBS on the final closing of its $471 million Oncology Impact Fund, which is aimed at developing cancer treatments

28 April 2016

King & Wood Mallesons launches joint report on Cross-Border RMB Market

This report highlights the channels that are available and new initiatives that are underway in the cross-border RMB market.

27 April 2016

King & Wood Mallesons advises Lonsdale Capital Partners LLP on the close of its £110 million fund

KWM has advised Lonsdale Capital Partners LLP on the close of its first fund at its target and hard-cap amount of £110 million

19 April 2016

King & Wood Mallesons bolsters London Capital Markets offering with new partner Greg Stonefield

KWM has continued to bolster its capital markets and London Corporate practice with the addition of senior M&A and ECM specialist Greg Stonefield

22 March 2016

King & Wood Mallesons secures green light from European Commission for China General Nuclear joint venture with EDF

A cross-border King & Wood Mallesons team has assisted China General Nuclear in obtaining EU merger clearance for its nuclear joint venture with EDF.

11 March 2016

King & Wood Mallesons: Rudolf Haas joins the Corporate team as a new partner in Frankfurt

Rudolf Haas joins the Corporate team as a new partner in Frankfurt

02 March 2016